Disseminated burkitt's lymphoma after kidney transplantation: A case report in a boy with drash syndrome

American Journal of Pediatric Hematology/Oncology

Volumn 19, Issue 2, 1997, Pages 151-155

  Ferrari, A ^a   Perotti, D ^a   Giardini, R ^a   Ghio, L ^a   Riva, S ^a   Massimino, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Burkitt's lymphoma; Drash syndrome; Key Words; Posttransplantation malignancies

Indexed keywords

CYCLOSPORIN; PREDNISOLONE;

ALLOGRAFT; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INCIDENCE; CASE REPORT; DRASH SYNDROME; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHILD; HUMANS; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME;

EID: 0030907619     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199703000-00011     Document Type: Article

References (35)

1. Penn I. Malignant lymphoma in organ transplant recipients. Transplant Proc 1981;13:736-8.
2. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990;323:1767-8.
3. Penn I. De novo malignancy in pediatric organ transplant recipients. J Pediatr Surg 1994;29:221-8.
4. Melosky B, Karim M, Chui A, et al. Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression. J Am Soc Nephrol 1992;2S:290-4.
5. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985;39:461-72.
6. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981;41:4253-61.
7. Wilkinson AH, Smith JL, Hunsicker LG, et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine and prednisone. Transplantation 1989;48:293-6.
8. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984;1:583-7.
9. Drash A, Sherman F, Hartmann WH, et al. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension and degenerative renal disease. J Pediatr 1970;76:585-93.
10. Eddy AA, Mauer SM. Pseudohermaphroditism, glomerulopathy and Wilms' tumor (Drash syndrome): frequency in end stage renal failure. J Pediatr 1985;106:584-7.
11. Gasparini M, Rottoli L, Massimino M, et al. Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapy. Eur J Cancer 1993;29A:692-8.
12. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982:545.
13. Dambaugh T, Hennessy K, Chamnankit L, et al. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 1984;81:7632-6.
14. Hennessy K, Kieff E. A second nuclear protein is encoded by Epstein-Barr virus in latent infection. Science 1985;227:1238-40.
15. Della Torre G, Pilotti MA, Rilke F, et al. Epstein-Barr virus genome in undifferentiated and squamous cell nasopharyngeal carcinomas in italian patients. Diagn Mol Pathol 1994;3:32-7.
16. Jadresic L, Wadey RB, Buckle B, et al. Molecular analysis of chromosome region 11p13 in patients with Drash syndrome. Hum Genet 1991;86:497-501.
17. Coopes MJ, Liefers GJ, Higughi M, et al. Inherited WT1 mutation in Denis-Drash syndrome. Cancer Res 1992;52:6125-8.
18. Coppes MJ, Huff V, Pelletier J. Denis-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr 1993;123:673-8.
19. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133:173-92.
20. Tokoro Y, Asano T, Nakagouri T, et al. A statistical study of cancer incidence in renal transplant patients. Transplant Proc 1992;24:1588-90.
21. Bordes-Aznar J, Mancilla E, Rosenblum M, et al. Malignant neoplasms in renal transplant patients: a 24-year experience. Transplant Proc 1992;24:1802-3.
22. Gruber SA, Gillingham K, Southern RB, et al. Cancer development in pediatric primary renal allograft recipients. Transplant Proc 1994;26:3-4.
23. Beveridge T, Krupp P, McKibben C. Lymphomas and lymphoproliferative lesions developing under cyclosporine therapy. Lancet 1984;1:788-94.
24. Chu SH, Lai MK, Huang CC, et al. Lymphoma in cyclosporinetreated renal transplant recipients. Transplant Proc 1992;24:1594-5.
25. Vilardell J, Oppenheimer F, Talbot-Wright R, et al. Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine. Transplant Proc 1992;24:1948.
26. Penn I. Immunosuppression-A contributory factor in lymphoma formation. Clin Transplant 1992;6:214-9.
27. Shell AG. Cancer in organ transplant recipients: part of an induced immune deficiency syndrome. Br Med J 1984;288:659-60.
28. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981;41:4264-71.
29. Hanto DW, Gajl-Peczalska KJ, Frizzera G, et al. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg 1983;198:356-9.
30. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995;85:552-65.
31. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr virusinduced B-cell lymphoma after renal transplantation: acyclovir and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1992;306:913-8.
32. Ho M, Jaffe R, Miller G, et al. The frequency of EBV infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988;45:988-9.
33. Klein G, Purtilo D. Symposium on Epstein-Barr virus induced lymphoproliferative diseases in immunodeficient patients [Summary]. Cancer Res 1981;41:4302-4.
34. Patte C, Philip T, Rodary C, et al. High survival rate in advancedstage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 1991;9:123-32.
35. Schwenn MR, Blattner SR, Lynch E, Weinstein HJ. HIC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 1991;9:133-8.